Measles cases in the U.S. are at the highest level in more than a decade, with nearly half of those involving children whose parents rejected vaccination, health officials reported Thursday.
An expensive vaccine aimed at preventing cervical cancer makes sense for young teens when it comes to cost-effectiveness, but not for women in their 20s, contends a new report
An expensive vaccine aimed at preventing cervical cancer makes sense for young teens when it comes to cost-effectiveness, but not for women in their 20s, contends a new report.
This week, more than 25,000 people from the global HIV/AIDS community are in Mexico City, Mexico, attending the XVII International AIDS Conference. I am pleased to be among them.
Plans for a large-scale trial of a potential AIDS vaccine are being dropped in favor of a smaller, more focused study, the National Institutes of Health said Thursday
A vaccine designed to prevent cervical cancer is coming under fresh scrutiny amid thousands of complaints linking it to a range of health problems.
A federal advisory panel has endorsed a second vaccine to combat a common and potentially fatal virus that causes diarrhea and vomiting in children
Merck's drug against HPV has been a boon to the company but is facing growing grass-roots opposition
Five years ago, Kathye Petters-Armitage's first child received the exact vaccinations on the exact schedule recommended by her pediatrician.
The first experimental bird flu vaccine made from lab-grown cells instead of chicken eggs shows promise in blocking the highly lethal virus, scientists report
Measles cases in the U.S. are at the highest level in more than a decade, with nearly half of those involving children whose parents rejected vaccination, health officials reported Thursday.
An expensive vaccine aimed at preventing cervical cancer makes sense for young teens when it comes to cost-effectiveness, but not for women in their 20s, contends a new report
An expensive vaccine aimed at preventing cervical cancer makes sense for young teens when it comes to cost-effectiveness, but not for women in their 20s, contends a new report.
This week, more than 25,000 people from the global HIV/AIDS community are in Mexico City, Mexico, attending the XVII International AIDS Conference. I am pleased to be among them.
Plans for a large-scale trial of a potential AIDS vaccine are being dropped in favor of a smaller, more focused study, the National Institutes of Health said Thursday
A vaccine designed to prevent cervical cancer is coming under fresh scrutiny amid thousands of complaints linking it to a range of health problems.
A federal advisory panel has endorsed a second vaccine to combat a common and potentially fatal virus that causes diarrhea and vomiting in children
Merck's drug against HPV has been a boon to the company but is facing growing grass-roots opposition
Five years ago, Kathye Petters-Armitage's first child received the exact vaccinations on the exact schedule recommended by her pediatrician.
The first experimental bird flu vaccine made from lab-grown cells instead of chicken eggs shows promise in blocking the highly lethal virus, scientists report
A woman whose child carried the virus back from Europe urges education about vaccination
Parents are opting out of shots for their kids. What the science says about the risks--and what you should do
Testimony resumed Monday in a long-running case involving thousands of children with autism that their parents contend was triggered by an early childhood vaccination.
Attorneys will attempt to show that vaccines with the thimerosal preservative triggers symptoms of autism
Three months before she gave birth last year, Diana Simpson, a dental hygienist in Davison, Michigan, started coughing uncontrollably. The pain in her throat and chest was unbearable.
The Food and Drug Administration has ordered Merck & Co. to correct numerous manufacturing deficiencies at its main vaccine plant, the latest in a string of setbacks for the drugmaker
Polio cases have nearly doubled this year in the West African nation of Nigeria as officials struggle to fight various natural strains of the virus as well as an outbreak set off by the polio vaccine itself three years ago
This year's flu season has shaped up to be the worst in three years, partly because the vaccine didn't work well against the viruses that made most people sick
This week, the world has come together to focus on a major public health issue that affects thousands of children and their families around the world -- autism.
In light of the recent Hannah Poling decision, in which the federal court conceded that vaccines could have contributed to her autism, we think the tide is finally turning in the direction of parents like us who have been shouting concerns from our rooftops for years.
This week, the world has come together to focus on a major public health issue that affects thousands of children and their families around the world -- autism.
At 13, Michelle Cedillo can't speak, wears a diaper and requires round-the-clock monitoring in case she has a seizure. While her peers go to school or the mall or spend time with friends, the Yuma, Arizona, teenager remains at home, where she entertains herself with picture books and "Sesame Street" and "Blue's Clues" DVDs.
The parents of a 9-year-old girl with autism said Thursday that their assertion that her illness was caused by childhood vaccines has been vindicated by the federal government's decision to compensate them.
A Florida-based company's artificial immune system promises to make testing of new vaccines faster, cheaper and safer
What does the case of 9-year-old Hannah Poling tell us about a link between vaccines and autism?
I'm the mother of two daughters, a teen and a tween. So every day, I tiptoe through hormonally laced minefields hoping to avoid emotional carnage in response to any of my random comments or actions.
Argentinians planning to travel to the northern part of the country, Brazil and Paraguay were lining up for vaccinations Tuesday, because of a yellow fever breakout that has killed at least 21 people in the region.
New research finds Tamiflu-resistant strains of the most common flu virus popping up all over the world
A CDC survey finds that American adults are failing to get themselves immunized, putting themselves at unnecessary risk for disease
An experimental vaccine may help cocaine addicts break the cycle of dependency. Other addiction vaccines could follow
A routine childhood vaccine is being recalled, sparking a shortage -- but no real health risks. Alice Park explains the recall
The recall of a routine vaccine for babies due to contamination risks could trigger a shortage and likely will alarm parents, but officials said there is no known health threat
The drugmaker Merck & Co. said Tuesday that it will seek federal approval for two new experimental drugs next year, adding that it's on track to meet its sales targets.
Some major US airports are offering flu shots to travelers as they pass through security checkpoints
A crowd of frustrated parents gathered on a chilly Saturday morning outside Prince George's County Circuit Court to comply with an order from the school system to have their children vaccinated -- or else.
A new study shows that immunizations have prevented a record number of deaths in the U.S. So, what's the fuss over vaccines?
Merck's promising AIDS vaccine candidate turned out to be an absolute failure in trials, but it may still pave the way for future success
Nobody wants to get the flu this year. The dreaded, head-pounding, body-aching, feverish, nauseating, cough-fest packs equal parts misery and inconvenience.
The polio eradication campaign has made remarkable strides in Nigeria. But a recent outbreak -- caused by the vaccine itself -- threatens to derail it
Merck's cervical cancer vaccine Gardasil now faces direct competition from Glaxo's Cervarix, which was approved by European health authorities, said the vaccine's maker GlaxoSmithKline on Monday.
A promising experimental vaccine to prevent the AIDS virus has failed in a crucial experiment, with volunteers becoming infected with HIV anyway, leading the drug developer to halt the study.
After years of shortages and confusion, this fall promises plenty of flu vaccine to go around -- up to 132 million doses, more than the nation has ever produced
The FDA has approved the vaccine only for girls and women up to age 26. Now a medical debate is raging over whether older women should get it too
Men should be vaccinated against a sexually transmitted wart virus to protect them against a type of mouth and throat cancer, U.S. researchers said Monday.
TThe drug helps protect teenage girls from the virus that can cause cervical cancer, but a new study shows it does little to help women who already are already infected
Merck & Co. said Monday that quarterly earnings rose 12 percent on strong demand for its newer vaccines and medicines, and raised its 2007 profit forecast, sending its shares up nearly 8 percent.
The French government has agreed to subsidize a cervical cancer vaccine made by Merck for teenage girls and young women, according to Merck's marketing partner, French drugmaker Sanofi-Aventis.
GlaxoSmithKline announced the results of the biggest-ever study of a cancer vaccine Wednesday, in the hopes of bolstering the competitive strength of its Cervarix against Merck's Gardasil.
Authorities in northern Nigeria have filed a $2 billion civil case and were preparing criminal charges against the U.S. drug company Pfizer
The drugmakers Merck, Schering-Plough and Wyeth all reported strong first-quarter earnings - with Schering and Wyeth trouncing forecasts - but investor reaction was mixed.
The Centers for Disease Control and Prevention recommends children be immunized to protect them from dangerous childhood diseases.
GlaxoSmithKline said it submitted an application for its cervical cancer vaccine Cervarix to the Food and Drug Administration, bringing it one step closer to challenging Merck's now-dominant Gardasil.
Centuries ago, people believed epidemics were caused by the stars' influence, thereby giving influenza its name.
GlaxoSmithKline is getting closer to launching its challenge against Merck's monopoly on cervical cancer vaccines.
The Food and Drug Administration approved GlaxoSmithKline's breast cancer drug Tykerb, the drug company said Tuesday.
A panel of FDA advisers voted to recommend approval of an experimental bird flu vaccine from the French drugmaker Sanofi-Aventis determining that it was safe and effective for the U.S. population, the company and the FDA said Tuesday.
Worried about bird flu? If Sanofi has its way, America could soon be getting its first FDA-approved vaccine.
This time last year, Kleiner Perkins Caufield & Byers gambled big. Amid all the headlines and hand-wringing over fears of a looming flu outbreak that could kill millions of people, the prominent venture capital firm formed a $200 million fund to invest in new pandemic drugs and vaccines.
Iomai Corp. is developing a skin patch meant to give a broad boost to what is expected to be a national stockpile of bird flu vaccines, the biotech company's CEO said Monday.
The British drugmaker GlaxoSmithKline fired a shot over Merck's bow on Thursday, by launching a study comparing its own experimental vaccine for cervical cancer to Merck's Gardasil.
The U.S. government awarded Novartis and GlaxoSmithKline contracts worth more than $100 million to develop vaccines to protect against the possibility of a bird flu pandemic, the drug companies said.
STOCKHOLM -(Dow Jones)- Danish vaccine manufacturer ALK-Abello A/S (ALK-B.KO) said Wednesday it has signed a deal with Schering-Plough Corp. (SGP) of the U.S. to develop its tablet-based allergy vaccines for North America, sending shares up as much as 17% in early trading.
A year ago, headlines were screaming about a looming disaster: the rapid spread of bird flu across two-thirds of the globe. The H5N1 strain of the virus was killing more than half its human victims. Experts were urging the government to stockpile medicine and experimental vaccines.
On the site of a former amusement park in a small Pennsylvania town, technicians sheathed in plastic suits labor over stainless steel fermentation tanks that look like brewery vats.
Now doctors have their own online community, where they discuss everything from the latest medical break-throughs to potentially faulty drugs.
As the flu season heads into its traditional peak period, health officials are urging the public to take advantage of the record number of vaccines available.
Scientists have discovered a new strain of bird flu that has infected humans in China, which could arouse fresh fears of a possible pandemic and spur further interest in experimental drugs and vaccines.
Here's the good news for consumers: There's no flu vaccine shortage this year; in fact, 2006 will probably be a record year for vaccine production.
Merck & Co. reported reduced earnings, but still managed to edge past Wall Street expectations, even though Vioxx-related lawsuits against the company continue to mount.
Common misconceptions about influenza and the flu vaccine may be preventing people from getting vaccinated, a new survey has found.
The next time someone tells you that an unfettered free market can solve all of our social problems, ask them why it is taking so long to develop a vaccine to combat the worst epidemic since the Spanish flu pandemic of 1918.
A British company announced this week that it has developed the first effective small-dose bird flu vaccine.
Merck's stock price is starting to climb out of its hole this year, but the drug giant still faces a long uphill climb fraught with obstacles if it ever plans to get to its pre-Vioxx scandal levels.
The U.S. Food and Drug Administration on Thursday approved the first vaccine for cervical cancer -- Gardasil, manufactured by Merck and Co.
Federal regulators approved Gardasil, the first vaccine meant to prevent cervical cancer, the drugmaker Merck said Thursday.
Vital protection against cervical cancer could soon be made available, not just from Merck but also from GlaxoSmithKline, providing life-saving potential for women while feeding a competitive atmosphere for the drug giants.
Merck has already angered Christian conservatives by pushing to make its yet-to-be approved cervical cancer vaccine, Gardasil, mandatory for girls as young as nine. But that could be the least of the company's worries regarding the projected $4 billion-a-year vaccine.
Despite the Memorial Day holiday, there was no rest for obesity researchers in the major medical journals.
The FDA has approved Zostavax, a new vaccine from Merck that prevents shingles, for patients 60 or older.
Stock prices for biotechs developing bird flu drugs and vaccines surged, following news that six members of an Indonesian family died from the dreaded bird flu, sparking fears of human-to-human spreading despite official denials of a mutated strain.
An FDA advisory committee recommended for approval Merck's experimental cervical cancer vaccine Gardasil, said Merck and the agency.
Merck needs a hit, and it just might be on the verge of getting one, thanks to some delicate footwork with the religious right.
The U.S. Department of Health and Human Services awarded $1 billion to drugmakers, including nearly $700 million to GlaxoSmithKline, Novartis and MedImmune, to help them develop a faster method of producing an influenza vaccine to better protect the nation against the possibility of a pandemic.
Dr. Blaise L. Congeni has always been in a hurry.
An experimental bird-flu vaccine for humans has been deemed safe, but it provides only partial protection from the H5N1 strain of the virus, according to a study published this week.
Imagine a world without HIV. If that seems farfetched, then try to imagine there's an HIV vaccine.
A European Union panel Wednesday approved a plan to vaccinate poultry in France and the Netherlands against bird flu, in an effort to stop the spread of the disease in Europe.
For six hours on Nov. 8, 2005, time moved so slowly for Frank Burroughs and Steve Walker that it seemed to stop altogether. The two had come to a dreary ballroom at a Holiday Inn in Gaithersburg, M...
When Friday's announcement came it was hard to see it as anything but wonderful news -- the FDA had approved a vaccine called RotaTeq, made by Merck & Co., which had the potential to stop a deadly viral epidemic in its tracks.
On a recent afternoon, in stifling 100-degree heat, eight fragile children lie in cribs covered with mosquito nets in the pediatric ward of a small hospital in Navrongo, a rural town in the West Af...
Sanofi Pasteur expanded its bird flu contact with the U.S. government and shipped out thousands of experimental vaccine doses to build up stockpiles against the specter of a pandemic, the company said on Monday.
JUDGING BY THE HEADLINES, IT WOULD BE EASY TO THINK that Big Pharma is on the brink of collapse. In 2006 the industry is poised to lose more than $23 billion in sales to generic competitors, its wo...
Merck's big problem in 2006 isn't just Vioxx. It's Zocor.
Some biotech companies working on bird flu vaccines have seen their stocks zoom in recent months but investors take note: when the flu season ends, the firms could have a hard time keeping up their stock prices.
The race to become the leading bird flu battler is getting tighter, with a little Alabama biotech gaining on the front runner.
Merck, the second-biggest American drug maker, said on Friday that its experimental cervical cancer vaccine Gardasil can also prevent external genital lesions in women, including vaginal and vulvar lesions.
With Vioxx-related lawsuits increasing, Merck said at an analyst meeting Thursday that it has added up to $1 billion worth of projected cuts to its multibillion dollar plan to slash costs through 2010.
In a handful of warehouses, at secret locations in the United States, sit containers of vaccine that health officials fervently hope could head off an outbreak of the killer flu.
U.S. health officials believe there will be an ample supply of flu vaccine this winter and don't expect a repeat of last year's vaccine panic, but spot shortages have already been reported.
Roche, the Swiss drug maker, isn't producing enough Tamiflu to meet the demand for bird flu anti-virals, but a small, Philadelphia-based biotech believes it has found a way to stretch existing supplies.
| Most Viewed | Most Emailed | Top Searches |
| Most Viewed | Most Emailed | Top Searches |
Video
